Clinical Interventions and Diagnostics Branch
The Clinical Interventions and Diagnostics Branch supports research on the prevention, treatment, and management of individuals with or at-risk for cognitive decline, Alzheimer's disease, and related dementias. The branch supports all stages of clinical development for pharmacologic and nonpharmacologic interventions and combination therapies, as well as research on methods development and training for innovative trial design. The branch also supports research on diagnostics aimed at the development and evaluation of reliable and valid multidimensional diagnostic procedures and instruments, including imaging, fluid and digital biomarkers, and clinical and neuropsychological instruments for diagnosis, progression, and response to treatment. A central goal of the branch is the maintenance and development of research infrastructure for clinical trials and biomarkers development, which includes the national network of Alzheimer’s Disease Research Centers.
Branch Chief
Laurie Ryan, Ph.D.
Email Laurie Ryan
Clinical Interventions
Laurie Ryan, Ph.D.
Program Officer
Email Laurie Ryan
Kristina McLinden, Ph.D.
Program Officer
Email Kristina McLinden
Alvin McKelvy, Ph.D.
Health Science Specialist
Email Alvin McKelvy
Akanni Clarke, Ph.D.
Health Science Specialist
Email Akanni Clarke
Biomarkers and Diagnostics
John K. Hsiao, M.D.
Program Officer
Email John K. Hsiao
Alzheimer’s Disease Research Centers
Cerise Elliott, Ph.D.
Program Officer
Email Cerise Elliott
Nina Silverberg, Ph.D.
Program Officer
Email Nina Silverberg
Grayson Donley, M.S.
Program Specialist
Email Grayson Donley
Training and Technology
Yuan Luo, Ph.D.
Program Officer
Email Yuan Luo
Recruitment and Retention
Cerise Elliott, Ph.D.
Program Officer
Email Cerise Elliott